Maybe. Maybe not. Look at AI drug design - it's not really speeding up the important part - drug trials. There isn't really a coherent plan to use AI for the most complex part of drug discovery at all.
So, it doesn't appear there is any way to avoid the clinical trial process. And it won't speed up, and it won't get cheaper.
Am I wrong?